Landmark Study Shows GeneSight® Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder

    NEXT STORY
    RedHill Biopharma Announces Last Patient Assessed for Primary Endpoint in RHB-104 Phase III Study for Crohn’s Disease
    PREV STORY
    Chimerix Announces First Quarter 2018 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Agritek Holdings, Inc. Announces Focus on Production of CBG Enriched Hemp Material and Retail Products as New Research Uncovers Hidden Antibiotic Potential to Fight Viral Symptoms in Humans

    author_avatar
    NASDAQ Market News

    Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: Biocartis Establishes R&D Center in the US

      PRESS RELEASE: 1 March 2018, 07:01 CET Biocartis Establishes R&D Center in the US ...

    author_avatar
    NASDAQ Market News